학술논문

Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06)
Document Type
Article
Source
In: Journal for ImmunoTherapy of Cancer. (Journal for ImmunoTherapy of Cancer, 13 March 2024, 12(3))
Subject
Language
English
ISSN
20511426